Company intelligence / Profile preview

LumaBridge

San Antonio, Texas, United Stateslumabridge.com ↗

Ownership: Private
Development stage: Other

Overview

LumaBridge, formerly known as Cancer Insight, is an oncology-focused clinical research organization specializing in innovative clinical trial solutions. The company partners with emerging biopharma and biotech companies to advance novel immunotherapies and cancer treatments. It offers comprehensive CRO services including trial design, regulatory affairs, data management, medical writing, pharmacovigilance, and more. Founded by Dr. George Peoples—a pioneer in cancer immunotherapy—LumaBridge leverages deep academic and military research expertise to guide therapies from bench to clinic.

Therapeutic areas: Oncology
Modalities: Immunotherapy
Industry: Contract Research Organization

Partnerships

Parker Institute for Cancer Immunotherapy

Beyond the preview

Go deeper on LumaBridge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LumaBridge.

Explore the full profile